Translate to...

Johnson Johnson cuts price of TB drug Bedaquiline by 32%

Johnson  Johnson cuts price of TB drug Bedaquiline by 32%

Johnson  Johnson cuts price of TB drug Bedaquiline by 32% The World Health Organisation (WHO) recommends the oral drug Bedaquiline as the backbone of DR-TB treatment, to replace older, more toxic drugs that have to be injected daily and can cause intolerable side effects, such as deafness